查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404813

肉毒桿菌毒素市場規模、佔有率和趨勢分析報告：按產品類型、應用、最終用途、地區和細分市場預測，2024-2030 年

Botulinum Toxin Market Size, Share & Trends Analysis Report By Product Type (Type A, Type B), By Application (Therapeutic, Aesthetic), By End-use (Dermatology Clinics, Cosmetic Centers & Medspas), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

肉毒桿菌毒素市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球肉毒桿菌毒素市場規模將達211億美元，2024年至2030年複合年成長率為9.8%。

肉毒桿菌毒素是由肉毒桿菌產生的毒素所形成的藥物。這些藥物透過麻痺或放鬆某些肌肉或干擾某些神經來發揮作用。該藥物的效果永續數月，具體取決於治療方法。肉毒桿菌毒素可用於治療和美容。這種藥物現在廣泛用於整容手術。例如，肉毒桿菌是一種非侵入性美容手術，用於減少額頭皺紋、臉部細紋、皺紋、魚尾紋等。由於對微創或非侵入性整容手術的需求不斷成長，預計在預測期內對肉毒桿菌毒素的需求將會成長。此外，不斷增加的治療應用以及不斷增加的研發舉措預計將擴大市場。

40歲以上人群注重自己的身體特徵，希望擁有年輕的外表。因此，女性注重美容（例如唇部護理）的趨勢不斷成長，尤其是在已開發國家，預計將刺激該行業的成長。肉毒桿菌毒素也用於治療多種與老齡化相關的病症，例如魚尾紋、魚尾紋和額頭皺紋。因此，40歲以上的人更容易出現此類老化徵兆。因此，肉毒桿菌治療在40-55歲的人群中越來越受歡迎，促進了該行業的成長。此外，偏頭痛和頸部肌張力不全症等慢性疾病病例的增加也可能推動市場。

COVID-19 的疫情對市場產生了重大影響。最初，由於大多數國家的停工和全球限制，許多美容治療和手術被取消。 COVID-19大流行對整個醫療產業的供應鏈造成了嚴重破壞。然而，由於疫情期間需求增加，肉毒桿菌（如肉毒桿菌）的銷售量激增。多名整形外科醫生和皮膚科醫生已經證明，這種熱潮適合那些希望在參加線上會議和會議時展現最佳狀態並有更多時間從預約和手術中恢復的個人。

肉毒桿菌毒素市場報告亮點

  • 2023年，A類產品類型主導市場。這是因為包括Dysport和 Botox 在內的 A 型產品在大多數國家都有市售，並且經過臨床測試，證明長期安全有效，副作用很少。
  • 治療應用領域佔43.0%的市場佔有率。
  • 由於美容治療技術的不斷進步以及醫療專家和服務供應商數量的增加，2023年北美在全球市場中的收益佔有率將佔46.9%以上。
  • 由於患者人數不斷成長、美容手術意識不斷提高以及技術快速進步，亞太地區預計在預測期內複合年成長率最高，達到 11.1%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章肉毒桿菌毒素市場：變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 肉毒桿菌：市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • COVID-19感染疾病的影響分析

第4章肉毒桿菌毒素市場：產品類型細分分析

  • 肉毒桿菌毒素：2023 年和 2030 年產品類型市場佔有率分析
  • A型
  • B型

第5章肉毒桿菌毒素市場：應用細分分析

  • 肉毒桿菌毒素：2023 年和 2030 年應用市場佔有率分析
  • 治療
  • 美麗

第6章肉毒桿菌毒素市場：最終用途細分分析

  • 肉毒桿菌毒素：2023 年和 2030 年最終用途市場佔有率分析
  • 醫院
  • 皮膚科診所
  • 水療及美容中心

第7章肉毒桿菌毒素市場：區域分析

  • 肉毒桿菌毒素：2023 年和 2030 年區域市場佔有率分析
  • 北美洲
    • 北美肉毒桿菌毒素市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲肉毒桿菌毒素市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太肉毒桿菌毒素市場，2018-2030
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲肉毒桿菌毒素市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA 肉毒桿菌毒素市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 公司簡介

  • 主要市場參與企業的最新趨勢和影響分析
  • 肉毒桿菌毒素 -市場佔有率分析
  • Ipsen Group
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
  • Allergen Inc.
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
  • Medy-Tox, Inc.
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
  • Metabiologics
    • 公司簡介
    • 財務績效
    • 策略舉措
  • Merz Pharma
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
  • US Worldmeds
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
  • Evolus
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
  • Galderma
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
  • Lanzhou Institute Of Biological Products
    • 公司簡介
    • 財務績效
    • 產品基準評效
    • 策略舉措
Product Code: GVR-1-68038-355-3

Botulinum Toxin Market Growth & Trends:

The global botulinum toxin market size is expected to reach USD 21.1 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 9.8% from 2024 to 2030. Botulinum toxin is a drug formed from a toxin built by the bacteria clostridium botulinum. These drugs work by paralyzing or tempering specific muscles or by hindering certain nerves. The effect of the drug lasts for about a few months, depending on the treatment. Botulinum toxin is used for both therapeutic and aesthetic applications. Nowadays, the drug is highly adopted for aesthetic procedures. For instance, Botox is a non-invasive cosmetic procedure and is used to reduce forehead creases, facial fine lines, wrinkles, and crow's feet among others. The demand for botulinum toxin is expected to grow during the forecast period owing to the growing demand for minimally invasive or non-invasive procedures in aesthetics. Furthermore, increasing application in therapeutic applications, coupled with growing R&D initiatives, is expected to expand the market.

Population aged above 40 years are focusing on the physical features and wish to have a younger look. Thus, rising emphasis on aesthetic beauty, for instance, lip treatments by women, especially in developed countries is anticipated to fuel the industry growth. Also, botulinum toxin is used to treat several age-related conditions such as glabellar lines, crow's feet, and forehead lines. Hence, people above the age of 40 are more vulnerable to such signs of aging. Therefore, procedures of botulinum toxin are gaining more popularity among individuals aged between 40-55 years, thereby augmenting the industry growth. Furthermore, rising cases of chronic disorders such as migraine and cervical dystonia are likely to drive the market.

The COVID-19 outbreak has significantly affected the market. Initially, due to lockdown and global restrictions being imposed in most countries, many aesthetic treatments and procedures were halted. The COVID-19 pandemic has caused a huge disruption in the supply chain of the overall medical industry. However, the sales of botulinum toxins such as botox observed a surge due to the increased demand during the pandemic. Several plastic surgeons and dermatologists are accrediting the boom to individuals wishing to put their finest appearance for online meetings and conferences and greater time to attend consultations and recover from procedures.

Botulinum Toxin Market Report Highlights:

  • The type A product type segment dominated the market in 2023. This is because type A products including Dysport and Botox are commercially available in the market in most countries and have been clinically tested and proven to be safe and effective in the long term with minimal side effects.
  • The therapeutic application segment accounted for 43.0% of the market share
  • North America dominated the global market in 2023 with a revenue share of over 46.9% owing to the rising technological advancements for cosmetic treatments and the increasing number of specialists and service providers
  • Asia Pacific is expected to register the highest CAGR of 11.1% over the forecast period owing to the growing patient population, rising awareness regarding aesthetic procedures, and rapid technological advancements

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product Type
    • 1.1.2 Application
    • 1.1.3 End-Use
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Primary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2
    • 1.10.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Botulinum Toxin Market: Variables, Trends, & Scope

  • 3.1 Market Segmentation And Scope
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.2.1 Increasing Number Of Patients Having Neurological Disorders
      • 3.2.2.2 Rising Preference For Non-Invasive Or Minimally Invasive Procedures
      • 3.2.2.3 Increasing Concern Regarding Aesthetic Appearance In 40-54 Age Group Has Increased The Adoption Rate
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Cost Of Cosmetic Procedure
  • 3.3 Botulinum Toxin: Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
    • 3.3.2 Pestel Analysis
  • 3.4 COVID-19 Impact Analysis

Chapter 4 Botulinum Toxin Market: Product Type Segment Analysis

  • 4.1 Botulinum Toxin: Product Type Market Share Analysis, 2023 & 2030
  • 4.2 Type A
    • 4.2.1 Type A Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
      • 4.2.1.1 Botox
      • 4.2.1.2 Dysport
      • 4.2.1.3 Xeomin
      • 4.2.1.4 Others
    • 4.2.2 Type B
      • 4.2.2.1 Type B Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5 Botulinum Toxin Market: Application Segment Analysis

  • 5.1 Botulinum Toxin: Application Market Share Analysis, 2023 & 2030
  • 5.2 Therapeutic
    • 5.2.1 Therapeutic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
      • 5.2.1.1 Chronic Migraine
      • 5.2.1.2 Overactive Bladder
      • 5.2.1.3 Cervical Dystonia
      • 5.2.1.4 Spasticity
      • 5.2.1.5 Others
  • 5.3 Aesthetic
    • 5.3.1 Aesthetic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
      • 5.3.1.1 Glabellar Lines
      • 5.3.1.2 Crow's Feet
      • 5.3.1.3 Forehead Lines
      • 5.3.1.4 Others

Chapter 6 Botulinum Toxin Market: End-Use Segment Analysis

  • 6.1 Botulinum Toxin: End-Use Market Share Analysis, 2023 & 2030
  • 6.2 Hospitals
    • 6.2.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.3 Dermatology Clinics
    • 6.3.1 Dermatology Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4 Spas And Cosmetic Centers
    • 6.4.1 Spas And Cosmetic Centers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7 Botulinum Toxin Market: Regional Analysis

  • 7.1 Botulinum Toxin: Regional Market Share Analysis, 2023 & 2030
  • 7.2 North America
    • 7.2.1 North America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 U.S. Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Canada Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.3 Europe
    • 7.3.1 Europe Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.2 UK
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 UK Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Germany Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 France Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Italy Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Spain Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Denmark Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Sweden Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Norway Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.2 China
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 China Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.3 India
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 India Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.4 Japan
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Japan Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.5 South Korea
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 South Korea Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.6 Australia
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Australia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.4.7 Thailand
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Thailand Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.5 Latin America
    • 7.5.1 Latin America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Brazil Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Mexico Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.5.4 Argentina
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Argentina Botulinum Toxin Market, 2018 - 2030 (USD Billion)
  • 7.6 MEA
    • 7.6.1 MEA Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.2 South Africa
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 South Africa Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Saudi Arabia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.4 UAE
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 UAE Botulinum Toxin Market, 2018 - 2030 (USD Billion)
    • 7.6.5 Kuwait
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Kuwait Botulinum Toxin Market, 2018 - 2030 (USD Billion)

Chapter 8 Company Profiles

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Botulinum Toxin- Market Share Analysis
  • 8.3. Ipsen Group
    • 8.3.1 Company Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Benchmarking
    • 8.3.4 Strategic Initiatives
  • 8.4. Allergen Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Benchmarking
    • 8.4.4 Strategic Initiatives
  • 8.5 Medy-Tox, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Benchmarking
    • 8.5.4 Strategic Initiatives
  • 8.6 Metabiologics
    • 8.6.1 Company Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Strategic Initiatives
  • 8.7 Merz Pharma
    • 8.7.1 Company Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Benchmarking
    • 8.7.4 Strategic Initiatives
  • 8.8 US Worldmeds
    • 8.8.1 Company Overview
    • 8.8.2 Financial Performance
    • 8.8.3 Product Benchmarking
    • 8.8.4 Strategic Initiatives
  • 8.9 Evolus
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 Galderma
    • 8.10.1 Company Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Benchmarking
    • 8.10.4 Strategic Initiatives
  • 8.11 Lanzhou Institute Of Biological Products
    • 8.11.1 Company Overview
    • 8.11.2 Financial Performance
    • 8.11.3 Product Benchmarking
    • 8.11.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Strategic collaborations by key players

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Botulinum toxin market snapshot (2023)
  • Fig. 10 Botulinum toxin market segmentation
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's Five Forces analysis
  • Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 16 Botulinum toxin market product type outlook: Segment dashboard
  • Fig. 17 Botulinum toxin market: product type movement analysis
  • Fig. 18 Type A market, 2018 - 2030 (USD Billion)
  • Fig. 19 Type B market, 2018 - 2030 (USD Billion)
  • Fig. 20 Botulinum toxin market application outlook: Segment dashboard
  • Fig. 21 Botulinum toxin market: Application movement analysis
  • Fig. 22 Therapeutic market, 2018 - 2030 (USD Billion)
  • Fig. 23 Aesthetic market, 2018 - 2030 (USD Billion)
  • Fig. 24 Botulinum toxin market end-use outlook: Segment dashboard
  • Fig. 25 Botulinum toxin market: End-use movement analysis
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Billion)
  • Fig. 27 Dermatology clinics market, 2018 - 2030 (USD Billion)
  • Fig. 28 Cosmetic centers and medspas market, 2018 - 2030 (USD Billion)
  • Fig. 29 Regional market: Key takeaways
  • Fig. 30 Regional outlook: 2023 & 2030
  • Fig. 31 North America market, 2018 - 2030 (USD Billion)
  • Fig. 32 U.S. market, 2018 - 2030 (USD Billion)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada market, 2018 - 2030 (USD Billion)
  • Fig. 35 Key country dynamics
  • Fig. 36 Europe market, 2018 - 2030
  • Fig. 37 UK market, 2018 - 2030 (USD Billion)
  • Fig. 38 Key country dynamics
  • Fig. 39 Germany market, 2018 - 2030 (USD Billion)
  • Fig. 40 Key country dynamics
  • Fig. 41 France market, 2018 - 2030 (USD Billion)
  • Fig. 42 Key country dynamics
  • Fig. 43 Italy market, 2018 - 2030 (USD Billion)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain market, 2018 - 2030 (USD Billion)
  • Fig. 46 Key country dynamics
  • Fig. 47 Denmark market, 2018 - 2030 (USD Billion)
  • Fig. 48 Key country dynamics
  • Fig. 49 Sweden market, 2018 - 2030 (USD Billion)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway market, 2018 - 2030 (USD Billion)
  • Fig. 52 Key country dynamics
  • Fig. 53 Asia Pacific market, 2018 - 2030 (USD Billion)
  • Fig. 54 China market, 2018 - 2030 (USD Billion)
  • Fig. 55 Key country dynamics
  • Fig. 56 Japan market, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 India market, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 South Korea market, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia market, 2018 - 2030 (USD Billion)
  • Fig. 63 Key country dynamics
  • Fig. 64 Thailand market, 2018 - 2030 (USD Billion)
  • Fig. 65 Key country dynamics
  • Fig. 66 Latin America market, 2018 - 2030 (USD Billion)
  • Fig. 67 Brazil market, 2018 - 2030 (USD Billion)
  • Fig. 68 Key country dynamics
  • Fig. 69 Mexico market, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina market, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 MEA market, 2018 - 2030 (USD Billion)
  • Fig. 74 South Africa market, 2018 - 2030 (USD Billion)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia market, 2018 - 2030 (USD Billion)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE market, 2018 - 2030 (USD Billion)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait market, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics